Filter
226
Text search:
pharmacological
interventions
Featured
Recommendations
36
New Publications
38
Language
Document type
No document type
135
Guidelines
34
Studies & Reports
22
Manuals
15
Training Material
7
Strategic & Response Plan
6
Fact sheets
5
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
11
India
8
Kenya
8
Western and Central Europe
8
South Africa
6
Latin America and the Carribbean
6
Eastern Europe
5
Rwanda
4
Nigeria
3
Ethiopia
3
Asia
3
Uganda
2
Zimbabwe
2
Syria
2
Ukraine
2
Russia
2
Guinea
1
Sierra Leone
1
Liberia
1
Senegal
1
Ghana
1
Philippines
1
Nepal
1
South Sudan
1
Jordan
1
Germany
1
Tanzania
1
Cambodia
1
Bangladesh
1
Papua New Guinea
1
Peru
1
Eswatini/ Swaziland
1
Hungary
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Africa
1
Poland
1
Uzbekistan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
44
Clinical Guidelines
35
Public Health
15
Women & Child Health
13
Capacity Building
3
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
Mental Health
92
NCDs
17
COVID-19
9
TB
8
Caregiver
7
Pharmacy
7
HIV
6
AMR
6
Refugee
4
NTDs
3
Disability
2
Conflict
2
Planetary Health
2
Ebola & Marburg
1
Polio
1
Natural Hazards
1
Zika
1
Specific Hazards
1
Global Health Education
1
Social Ethics
1
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,
...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev
...
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with cessation of seizures and reduced adverse effects)?
...
Several diagnostic criteria of Post-traumatic Stress Disorder (PTSD) are remarkably similar to symptoms reported by individuals with depression, particularly as they manifest as cognitive processing deficits in children. Because of this overlap in profile and the high rate of comorbidity of PTSD and
...
Shaping Health programme on Learning from international experience on approaches to community power, participation and decision-making in health,AMHF, TARSC
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Otros trastornos
Capítulo H.4
Editores: Laura Borredá Belda, Matías Irarrázaval & Andres Martin
Traductores: Sara Diego Castaño, Laura Álvarez Bravos, Rebeca Santonja & Beatriz Ortega
Autres troubles
Chapitre H.4
Session outline
•Introduction to epilepsy.
•Assessment of epilepsy.
•Management of epilepsy.
•Follow-up of a person with epilepsy.
•Review or materials and skills.
The manual has been designed in a comprehensive manner, the aim being to provide a holistic approach to the short-term development of human resources, with a focus on primary care physicians. This is a reference manual meant for primary care physicians who will provide care to older people in primar
...
Psychiatry and Pediatrics
Chapter I.5
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
